Abstract
Rheumatic and joint diseases are among the most widespread pathologies associated with pain and cause a great impact in society across the globe. Given the continuing rise in life expectancy, their prevalence is destined to grow. Osteoarthritis, a degenerative joint disease, is on its way to becoming the fourth leading cause of disability worldwide by 2020. Accompanying osteoarthritis is rheumatoid arthritis, which is a chronic systemic disease that often causes pain and deformity. The joint function involves several processes and understanding the mechanism of action of the joint disease process (proliferation, degradation, regeneration, and infection) is important for the diagnostic, prophylaxis, and treatment. These mechanisms are associated with active peptides that are involved in almost all physiological processes, including cell differentiation, proliferation, inflammatory processes, and immune regulation. Therefore the study of bioactive peptides as biological markers and therapeutic targets for the diagnosis, prevention, and therapy of joint diseases has a very important research ahead. In this context, the present chapter will highlight the importance of bioactive peptides in joint health, underline peptides natural sources, their mechanisms of action, and their potential applications on joint diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.